Aqst Stock Forecast Fda Approval
Et by jaimy lee aquestive therapeutics started at outperform with $33 stock price target at wedbush Use our tools on your road to profit in the stock market. 2 Strong Buy Penny Stocks That Could Spike Over 200 Nasdaq Aqst) made a move this week, gaining about 17% monday after the fda approved one of its drugs ahead of a nov. Aqst stock forecast fda approval . As a result, aqst will have a straightforward path to approval, which could be faster and fairly inexpensive. Currently, aqst stock trades under $5, which gives it a market cap of about $180 million. Biotech stock catalyst and fda calendar for your biotech stock investing. The goal date set by the fda for announcing its decision on a company’s new drug application/ biologics license application/sbla/snda after reviewing the applications is known as the pdufa date. Nasdaq updated dec 4, 2021 12:44 am aqst 4.84 0.54 (10.04%). 26.4m short float 1.16% nasdaq:aqst company finance: Aqst) made a move this week, gaini...